Project description
Marine microbial natural products: from seabed to bedside
Biologically active compounds produced by microorganisms that live in marine environments have the potential to be developed into new drugs and treatments for various diseases. These marine microbial natural products often have unique structures and biological activities. With the support of the Marie Skłodowska-Curie Actions programme, the HOTBIO project will train early-stage scientists to bring these products from discovery to commercialisation. This involves every stage of the drug discovery pipeline, including microbial isolation, compound purification, identification, analogue synthesis and drug development. The project’s goal is to create a new generation of scientists that can bring these promising compounds to the bedside, where they can have a positive impact on human health.
Objective
The HOTBIO consortium will train a new generation of early-stage scientists to take marine microbial natural products from the seabed to the bedside. They will be involved in every stage of the pipeline from microbial isolation through compound purification and identification to making analogues with desirable drug-like properties. They will gain associated skills in access and benefit sharing, intellectual property and entrepreneurship. Students graduating from HOTBIO will be in a unique position to enter a challenging labour market as they will have received multidisciplinary training at world leading research groups in academia as well as at industry partners. Mentorship will be provided by industrial scientists and recent graduates from the MSCA ITN MarPipe.
The HOTBIO consortium consists of eight beneficiaries from seven European countries, including two members from non-academic sectors, that will host ten PhD students. Three more PhD students hosted by two Swiss associated partners will be funded by the Swiss State Secretariat for Education, Research and Innovation. In addition to secondments at the partners in Europe, students will also get the opportunity to do secondments in low-to-middle income countries (LMICs) in Africa and Asia to get a deeper understanding of how modern research can be done in resource-limited setting.
HOTBIO expands a conventional marine biodiscovery pipeline by including computer aided drug design (CADD), chemical synthesis of optimized compounds (i.e. medicinal chemistry), target deconvolution and extensive ADMET profiling. This will advance the bioactive microbial secondary metabolites to the later stages of preclinical development, and it will also inform the decisions and priorities of what kind of compounds that should be targeted in the initial phase of the drug discovery process. The downstream development will include hit compounds from earlier projects.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinator
9019 Tromso
Norway
See on map
Participants (6)
18100 Armilla Granada
See on map
80121 Napoli
See on map
24148 Kiel
See on map
87-100 TORUN
See on map
9050 GENT
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
44227 Dortmund
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (13)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
8006 Zurich
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1015 LAUSANNE
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3430 Tulln
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
24118 Kiel
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
18071 Granada
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
N/A LEGON ACCRA
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
87-100 Toruń
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
MK7 6AA Milton Keynes
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3000 Leuven
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
600119 Chennai
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
AB24 3FX Aberdeen
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
98122 Messina
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
44801 Bochum
See on map